ARTICLE | Company News
AstraZeneca, Eli Lilly deal
December 16, 2016 5:20 PM UTC
AstraZeneca and Eli Lilly partnered to co-develop MEDI1814. AZ will receive $30 million up front and is eligible for up to $350 million in development and commercialization milestones. The mAb against...